@AlethiaAlvarez @OmarOnco @elviscabrera7 @hectordelamora @DrHectorDiaz @joblagunes @BrizioMoreno @MiguelClara81 @SelnetH2020 la recomendación actual es segunda línea individualizando el esquema según características del paciente. https://t.co/VlL0O23Qvf h
1,708 followers
4,659 followers
Our infographic summarises the EURAMOS-1 trial results #osteosarcoma https://t.co/2KMX9VEBj9 https://t.co/EFAQjBPTPM
493 followers
Neyssa Marina & team published EURAMOS-1 results in Lancet Oncology: https://t.co/uWlMYzqGiq https://t.co/g6FTNa3S74
4,742 followers
In osteosarcoma w/ poor histological resp., no improved outcome w/ ifosfamide & etoposide added to std postop ther. https://t.co/ylMt2KZS1g